Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
linear decrease » linear increase (Expand Search)
lower decrease » larger decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
Showing 501 - 520 results of 21,342 for search '(( significantly ((lower decrease) OR (linear decrease)) ) OR ( significant decrease decrease ))', query time: 0.46s Refine Results
  1. 501
    Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment.

    Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  2. 502
    Flowchart of patient selection in this study.

    Flowchart of patient selection in this study. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  3. 503
    Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment.

    Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  4. 504
    Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment.

    Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 505
    Clinical features and cancer treatment in patients with breast cancer receiving letrozole and anastrozole.

    Clinical features and cancer treatment in patients with breast cancer receiving letrozole and anastrozole. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  6. 506
    S1 Data -

    S1 Data - by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  7. 507
    Clinical course of patient no.

    Clinical course of patient no. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  8. 508
    Linear mixed model results, fixed effects for time points, group, time points x group and univariate effects in the two groups WAD grades 2 and 3.

    Linear mixed model results, fixed effects for time points, group, time points x group and univariate effects in the two groups WAD grades 2 and 3. by Anneli Peolsson (7867601)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 509
    BA attenuated the decrease in the expression of ZO-1 and Occludin induced by LPS in Caco2 cells.

    BA attenuated the decrease in the expression of ZO-1 and Occludin induced by LPS in Caco2 cells. by Luqiong Liu (11537092)

    Published 2024
    Save to List
    Saved in:
  10. 510
    Effect of Bcl-xl on the tumorigenicity of MDCK cells in nude mice.

    Effect of Bcl-xl on the tumorigenicity of MDCK cells in nude mice. by Jiahao Zheng (807470)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 511
    The Date.

    The Date. by Chengyuan Hao (21615653)

    Published 2025
    “…The relevant low temperature index showed proper decreasing trend while the diurnal range of annual extreme temperature showed fluctuating<b>—</b>decreasing first and then increasing. …”
    Save to List
    Saved in:
  12. 512
    Comparison of histological lesion scores of lungs and brains from PRV-WT and PRV-UL4<sup>mut</sup> infected mice.

    Comparison of histological lesion scores of lungs and brains from PRV-WT and PRV-UL4<sup>mut</sup> infected mice. by Xiaohua Zhang (350570)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  13. 513
    Data for Fig 6D.

    Data for Fig 6D. by Xiaohua Zhang (350570)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  14. 514
    The UL4 mutation alleviates inflammasome activation and pyroptosis in PRV-infected cells.

    The UL4 mutation alleviates inflammasome activation and pyroptosis in PRV-infected cells. by Xiaohua Zhang (350570)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  15. 515
    PRV UL4 also promotes AIM2-inflammasome activation.

    PRV UL4 also promotes AIM2-inflammasome activation. by Xiaohua Zhang (350570)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  16. 516
    Comparison of histological lesion scores of lungs and brains from PRV-WT and PRV-UL4<sup>mut</sup> infected piglets.

    Comparison of histological lesion scores of lungs and brains from PRV-WT and PRV-UL4<sup>mut</sup> infected piglets. by Xiaohua Zhang (350570)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  17. 517
    The UL4 mutation alleviated inflammation in PRV-infected mice.

    The UL4 mutation alleviated inflammation in PRV-infected mice. by Xiaohua Zhang (350570)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 518
    Data for Fig 5D.

    Data for Fig 5D. by Xiaohua Zhang (350570)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 519
    The UL4 mutation alleviated inflammasome activation and pyroptosis in PRV-infected cells.

    The UL4 mutation alleviated inflammasome activation and pyroptosis in PRV-infected cells. by Xiaohua Zhang (350570)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 520
    PRV UL4 is a promotor of NLRP3 inflammasome activation.

    PRV UL4 is a promotor of NLRP3 inflammasome activation. by Xiaohua Zhang (350570)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: